Pharma & Bio
Lifestyle
Out of 18 Listed Advertising Agencies, Only One Meets All Three Criteria: "Growth, Profitability, and High Margins" [In-Depth Analysis of Wise birds Inc.] (Part 2)
As companies tighten their marketing budgets in the wake of an overall economic slowdown, the advertising industry is facing a deepening winter. Typically, the fourth quarter—which reflects the year-e…
Technology
Choi Jeong-yun, CEO of HealthyMed: “To Combat Drugs… We’ve Entered an Era Where Early Prevention and Detection Must Become Mainstream”
Choi Jeong-yun, CEO of HealthyMed. (Photo courtesy of HealthyMed)
“While treatment and rehabilitation are important, prevention and early detection must come first to prevent even greater social c…
Technology
BreezeBio Passes Regulatory Review; What Makes Its Delivery Platform—Chosen by Genentech—So Competitive?
U.S.-based gene therapy delivery platform company BreezeBio (formerly GeneEdit) has passed the technology evaluation required for a KOSDAQ listing under the technology exception track and has official…
Lifestyle
[Exclusive] Remedy is the only company to pass the technical evaluation for a portable X-ray tender in Odisha, India... ‘Likely to Win the Contract’
#Remedy, a company specializing in X-ray technology, has secured an exclusive contract opportunity in India’s massive public healthcare procurement market—which serves a population of 1.4 billion—afte…
Lifestyle
Weeding Out the Good from the Bad in the Wake of the Peptron, Inc. Shock... Why G2GBIO, Inc. Is Being Reevaluated
The so-called “Peptron, Inc. incident” appears to be reshaping the investment landscape in South Korea’s microsphere-based long-acting drug delivery platform market. While the potential for joint rese…
Lifestyle
A Hidden Gem Emerges Amid a Market Focused on Biotech Earnings... Three Reasons to Watch Remedy
The investment paradigm in the biotech and medical device market is rapidly shifting from a focus on mere “future value” to a focus on “companies backed by concrete performance and proven numbers.” Am…
Lifestyle
A Fortress-Like Partnership That Broke Through 11 Big Tech Giants: Leading 'K-Bio' into North America [In-Depth Look at Wise birds Inc. ①]
Wise birds Inc.(273060)is drawing attention as it begins in earnest to support domestic pharmaceutical and biotech companies in entering the U.S. direct-to-consumer (DTC) market. The company’s strateg…
Lifestyle
"First Company Under the Advanced Biotechnology Act," ViGenCell Inc., Set to Administer Treatment to First Patient Soon… Aims for Conditional Approval Next Year and a License-Out Deal in China
"Once treatment of the first patient begins, the next steps will be conditional approval, followed by technology export."With ViGenCell Inc.(308080)’s VT-EBV-N—the first treatment plan in Korea to rec…
Lifestyle
"All That's Left Is Commercialization"... Mezion Pharma Co., Ltd.'s Fontan Treatment Draws Interest from Global Big Pharma
Mezzion Pharma Co., Ltd.(140410)has further enhanced the scientific credibility of its Fontan patient treatment, “Udenafil,” by presenting research results demonstrating its efficacy in improving live…
Business·Industry
HLB INC.’s New Liver Cancer Drug Receives Third CRL… Delays in Approval Raise Concerns About Commercial Viability
HLB INC.(028300)’s new liver cancer drug, the combination therapy of “Riboceranib and Camrelizumab,” has received its third Complete Response Letter (CRL) from the U.S. Food and Drug Administration (F…